AVAX
COGT icon

Atlas Venture Associates XI’s Cogent Biosciences COGT Stock Holding History

Atlas Venture Associates XI’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$10.3M Buy
+916,196
New +$10.1M 1.63% 5

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Atlas Venture Associates XI's COGT Position: Q4 2020 in Review

Atlas Venture Associates XI opened a new position in Cogent Biosciences (COGT) in Q4 2020: 916,196 shares worth $10.3M. The stake represents 1.63% of the portfolio and ranks #5 among its holdings.

69 funds tracked by Wall St. Rank hold COGT as of Q4 2020.

  • Atlas Venture Associates XI held 916,196 shares of Cogent Biosciences worth $10.3M as of Q4 2020.
  • Cogent Biosciences was a new Atlas Venture Associates XI position in Q4 2020.
  • Cogent Biosciences made up 1.63% of Atlas Venture Associates XI's portfolio in Q4 2020, its #5 holding.
  • 69 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2020.

Based on Atlas Venture Associates XI's 13F filing for Q4 2020, filed 1 Feb 2021.